Literature DB >> 1660573

Magnetic resonance imaging of AIDS-related polyradiculopathy.

D Talpos1, R D Tien, J R Hesselink.   

Abstract

AIDS-related polyradiculopathy is a syndrome associated with cytomegalovirus infection. We report two cases of AIDS-related polyradiculopathy in which spinal T1-weighted MRI with gadolinium-DTPA showed enhancement of the pial lining of the conus medullaris, cauda equina, and lumbar nerve roots. Both patients clinically improved with ganciclovir treatment.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1660573     DOI： 10.1212/wnl.41.12.1996

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  6 in total

1.  Cytomegalovirus polyradiculopathy in HIV-infected patients.

Authors:  P A Meier; K T Stephan; S P Blatt
Journal:  J Gen Intern Med       Date:  1996-01       Impact factor: 5.128

Review 2.  CNS manifestations of cytomegalovirus infections: diagnosis and treatment.

Authors:  Matthias Maschke; Oliver Kastrup; Hans-Christoph Diener
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

3.  Acute infectious disorders of the spinal cord and its roots with gadolinium-DTPA enhancement in magnetic resonance imaging.

Authors:  S Engelter; P Lyrer; E W Radu; A J Steck
Journal:  J Neurol       Date:  1996-02       Impact factor: 4.849

4.  Magnetic resonance imaging of childhood Guillain-Barre syndrome.

Authors:  Ali Yikilmaz; Selim Doganay; Hakan Gumus; Huseyin Per; Sefer Kumandas; Abdulhakim Coskun
Journal:  Childs Nerv Syst       Date:  2010-06-17       Impact factor: 1.475

5.  Spinal cord and cauda equina MRI findings in metachromatic leukodystrophy: case report.

Authors:  Irene Toldo; Carla Carollo; Pier Antonio Battistella; Anna Maria Laverda
Journal:  Neuroradiology       Date:  2005-07-15       Impact factor: 2.804

6.  Magnetic resonance imaging of nerve root inflammation in the Guillain-Barré syndrome.

Authors:  J R Perry; A Fung; P Poon; N Bayer
Journal:  Neuroradiology       Date:  1994       Impact factor: 2.804
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.